phenyl-n-tert-butylnitrone has been researched along with Movement Disorders in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cai, Z; Chen, RF; Fan, LW; Lin, RC; Mitchell, HJ; Rhodes, PG; Simpson, KL | 1 |
Fairfax, DF; Gupta, SK; Henry, P; Khan, RF; Mishra, RK; N-Marandi, S; Rogoza, RM | 1 |
2 other study(ies) available for phenyl-n-tert-butylnitrone and Movement Disorders
Article | Year |
---|---|
alpha-Phenyl-n-tert-butyl-nitrone attenuates lipopolysaccharide-induced brain injury and improves neurological reflexes and early sensorimotor behavioral performance in juvenile rats.
Topics: Animals; Animals, Newborn; Brain; Brain Damage, Chronic; Central Nervous System Bacterial Infections; Cyclic N-Oxides; Disease Models, Animal; Female; Gait Disorders, Neurologic; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Leukomalacia, Periventricular; Lipopolysaccharides; Male; Movement Disorders; Myelin Basic Protein; Nerve Fibers, Myelinated; Neuroprotective Agents; Oligodendroglia; Pregnancy; Rats; Rats, Sprague-Dawley; Recovery of Function; Reflex | 2008 |
Electron spin resonance spectroscopy reveals alpha-phenyl-N-tert-butylnitrone spin-traps free radicals in rat striatum and prevents haloperidol-induced vacuous chewing movements in the rat model of human tardive dyskinesia.
Topics: Analysis of Variance; Animals; Antipsychotic Agents; Apomorphine; Behavior, Animal; Binding Sites; Corpus Striatum; Cyclic N-Oxides; Disease Models, Animal; Dopamine Agonists; Drug Interactions; Dyskinesia, Drug-Induced; Electron Spin Resonance Spectroscopy; Haloperidol; Humans; Male; Mastication; Motor Activity; Movement Disorders; Neuroprotective Agents; Nitrogen Oxides; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Receptors, Dopamine D2 | 2004 |